Abstract
Loss of myelin in the brain may lead to cognitive decline in Alzheimer's disease (AD). The ratio of T1 weighted/T2 weighted (T1w/T2w) on magnetic resonance imaging has been used as a proxy for myelin content in the brain. Using this approach, we investigated the correlation between the white matter (WM) T1w/T2w ratio and both cognitive scores and disease progression in AD. A total of 93 participants who were cognitively unimpaired or diagnosed with mild cognitive impairment or AD dementia were recruited between March 2021 and November 2022. All participants were assessed using neuropsychological tests, and a subset of the participants was assessed every 1 year to monitor disease progression. We observed significant positive associations between the WM T1w/T2w ratio and executive function within the fornix, sagittal stratum, anterior internal capsule, and body of the corpus callosum (False discovery rate [FDR]-corrected P-value < 0.05). There was a marginal interaction between the WM T1w/T2w ratio of the left anterior internal capsule and the longitudinal change in sum of boxes of the Clinical Dementia Rating Scale (FDR-corrected P-value = 0.05). The present study demonstrated that the WM T1w/T2w ratio was associated with executive function and disease progression, suggesting that it may be a novel neuroimaging marker for AD.
Similar content being viewed by others
Introduction
Amyloid beta (Aβ), tau deposition, and neurodegeneration are key pathological processes in Alzheimer’s disease (AD)1,2. However, there is evidence that myelin fibers also become damaged and that myelin pathology may even precede Aβ and tau pathology3. Many magnetic resonance imaging (MRI) techniques such as diffusion tensor imaging4, multi-echo T25, myelin water fraction6, and magnetic transfer techniques7 have been developed to measure myelin in the brain.
Given that the myelin content covaries with both T1w and T2w intensities, but in opposite directions, a previous study proposed that the ratio of T1 weighted to T2 weighted (T1w/T2w) MR images might be indicative of the myelin levels in the cerebral cortex with increased contrast to noise by cancelling the MR-related intensity bias field8,9. Previous studies have also applied T1w/T2w to white matter (WM) tracts in neonatal10,11,12 and adult brains13,14 and demonstrated its use in detecting white matter damage in normal-appearing white matter in patients with multiple sclerosis14. The advantage of T1w/T2w MR over other techniques is that it can be performed using conventional MRI without the need for additional MRI sequences.
Considering the number of studies showing changes in white matter (WM) myelin content in AD15,16,17, it is surprising that no previous studies have evaluated the WM T1w/T2w ratio in AD, whereas several studies have evaluated the gray matter (GM) T1w/T2w ratio in AD18,19.
Interestingly, previous studies applying the T1w/T2w MRI technique to the brain GM have shown conflicting results; one study showed a decrease in the T1w/T2w ratio in the inferior parietal lobule in early AD18 whereas another study showed an increase in the T1w/T2w ratio in AD19. These conflicting results may be because the T1w/T2w ratio also reflects tissue microstructures other than myelin, such as axon and dendrite densities and iron content20.
Changes in myelin content, fiber density, and iron content are important pathological changes in AD3. Therefore, we hypothesized that the WM T1w/T2w ratio is associated with cognitive function in AD. In this study, we measured the WM T1w/T2w ratio and evaluated its association with function in different cognitive domains to understand how this myelin proxy reflects the WM in patients with AD.
Methods
Study population
Data were collected from the Dementia Clinic of Dongguk University Ilsan Hospital in Goyang, Republic of Korea. Subjects aged 45–90 years, who were either cognitively unimpaired (CU) or diagnosed with mild cognitive impairment (MCI) or AD dementia (ADD) were recruited between March 2021 and November 2022. To be included as CU subjects, participants required a normal neurological examination and a clinical dementia rating of 0. Participants with MCI met Petersen’s criteria21 and those with ADD met the criteria for the clinical diagnosis of AD according to the National Institute of Neurological and Communicative Disorders Association22.
All participants completed the Seoul Neuropsychological Screening Battery (SNSB), a detailed neuropsychological test assessing attention, language, visuospatial, memory, and executive functions23. A subset of participants (n = 56) was assessed once per year for one to two years to monitor disease progression.
Participants also underwent laboratory tests, including complete blood count, blood chemistry assessment, vitamin B12 and folate evaluation, syphilis serological assessment, and thyroid function tests. Brain MRI confirmed the absence of structural lesions, including territorial cerebral infarction, brain tumor, hippocampal sclerosis, and vascular malformation.
The study protocol was approved by the Institutional Review Board of Dongguk University Ilsan Hospital, and informed consent was obtained from each participant according to the guidelines outlined in the Declaration of Helsinki.
MRI acquisition and processing
T1-, T2-, and fluid-attenuated inversion recovery (FLAIR) MR images were acquired using a 3.0 T MRI scanner (Skyra, Siemens Healthcare, Erlangen, Germany) with a standard head coil.
T1w MR images were obtained using 3D T1-weighted magnetization-prepared rapid gradient-echo (MP-RAGE) imaging (repetition time (TR) = 1800 ms, echo time (TE) = 2.26 ms, inversion time (TI) = 900 ms, voxel size = 0.5 × 0.5 × 0.5 mm3, slice thickness = 0.5 mm, no intersection gap, matrix size, 256 × 256, field of view (FOV) = 256 × 256 mm, number of excitation (NEX) = 1). T1w MP-RAGE images are perpendicular to the oblique T2w MR images.
T2w MR images were obtained using thin-section oblique coronal T2-weighted imaging (TR = 5170 ms, TE = 77 ms, voxel size = 0.43 × 0.43 × 3 mm3, slice thickness = 3 mm, no intersection gap, matrix size, 358 × 512, FOV = 220 × 220 mm, NEX = 1).
FLAIR images were obtained using standard axial FLAIR imaging (TR 9000 ms, TE = 124 ms, TI = 2500 ms, voxel size = 0.57 × 0.57 × 5 mm3, slice thickness = 5 mm, intersection gap = 2 mm, matrix size = 235 × 384, FOV = 193 × 220 mm, NEX = 2). To measure the global white matter hyperintensity (WMH) volume, we used the Lesion Segmentation Tool (LST) (https://www.applied-statistics.de/lst.html), which is widely used to automatically segment24 WMH. Previous studies have shown strong correlations between the Fazekas scale and automatic segmentation of hyperintense WMH25,26.
To measure cortical thickness, we performed cortical reconstruction and segmentation using FreeSurfer (version 7.4.1), and the cortical thickness for each of the 68 Desikan-Killiany-based regions of interest (ROI) was calculated (https://surfer.nmr.mgh.harvard.edu/) (Supplementary Fig. 1).
T1w/T2w ratio mapping
T1w/T2w ratio mapping was processed based on the workflow MRtool2 implemented in Statistical Parametric Mapping (SPM) software (http://www.fil.ion/uc.ac.uk/spm), as described by Ganzetti et al.27. This standardized pipeline comprises bias correction and intensity calibration on both T1w and T2w images and the subsequent computation of the ratio value between the pre-processed T1w and T2w images. Briefly, the original T2w image was first co-registered with the T1w image through a rigid-body transformation. Next, we bias-corrected the T1w and T2w images separately. After correcting for intensity nonuniformity, the T1w and T2w images were further processed to standardize their intensity using a linear scaling procedure. After calibrating the T1W and T2W images, the ratios were calculated to generate a calibrated ratio map. For subsequent analysis, we spatially transformed the calibrated ratio map from the individual subject space to the Montreal Neurological Institute (MNI) space and extracted the GM and WM components of the T1w/T2w ratio maps using probability maps with a threshold of 0.2.
Neuropsychological test scores
All participants were assessed using neuropsychological tests, including the Mini-Mental State Examination (MMSE) for global cognition and the SNSB for each cognitive domain. We used four domain-specific tests: executive function (Controlled Oral Word Association Test, Korean –Color Word Stroop Test, and Korean-Trail Making Test B), visuospatial function (Rey Complex Figure Copy), language (Korean-Boston Naming Test), and memory (Seoul Verbal Learning Test: delayed recall). The scores were converted to z-scores based on norms corresponding to participants’ age and education. Executive function was assessed using a composite score, which is the average of three domain-specific tests. To measure disease progression, we used the sum of boxes of the Clinical Dementia Rating Scale (CDR-SB), which was performed once a year for a subset of participants. CDR-SB is the sum of the six domains of CDR and has been used to assess both cognitive and functional impairments in AD28. It has been shown to be more reliable than other cognitive measures and has been used in intervention trials to track the progression of cognitive impairment in the early stages of AD29.
Statistical analysis
To analyze the association between the T1w/T2w ratio and cognitive performance, we used ROIs for the WM tracts. The ROIs were derived from the Johns Hopkins University (JHU) WM atlas (https://identifiers.org/neurovault.collection:264) of 48 WM tracts. Among the 48 tracts, the T1w/T2w ratio was not calculated for the bilateral tapetum. Therefore, 46 WM tracts were evaluated in subsequent analyses (Supplementary Fig. 1, Supplementary Table 1).
Association with cognitive state
We first compared the global WM T1w/T2w ratio by averaging the T1w/T2w ratio across 46 WM tracts. Group differences in WM T1w/T2w ratio was tested by one-way ANOVA, followed by post hoc two-sample T-tests if ANOVA was significant (P-value < 0.05).
To evaluate the association between WM T1w/T2w ratio and cognitive state, we performed the following linear regression analysis expressed as: WM T1w/T2w ratio (for each ROI) = β0 + β1 age + β2 sex + β3 education year + β4 WMH volume (log transformed) + β5.
MCI + β6ADD.
Association with cognitive performance
To evaluate the association between WM T1w/T2w ratio and cognitive score, we performed the following linear regression analysis expressed as: Cognitive score = β0 + β1 age + β2 sex + β3 education year + β4 WMH volume (log transformed) + β5 WM T1w/T2w ratio (for each ROI).
Association with disease progression
To investigate whether WM T1w/T2w ratio modified the longitudinal change of CDR-SB over time, the linear mixed effect model was used, expressed as: CDR-SB = β0 + β1 age + β2 sex + β3 education year + β4 WMH volume (log transformed) + β5 time + β6 WM T1w/T2w ratio + β7 time × WM T1w/T2w ratio + 1|subject. Given the variability in the CDR-SB at baseline, we used a linear mixed-effect model with random intercepts. The effect of the WM T1w/T2w ratio on the longitudinal change in CDR-SB over time was tested using the time × WM T1w/T2w ratio interaction term.
An independent analysis was performed for each WM tract region of interest (ROI). To control for multiple comparisons, we corrected the false discovery rate (FDR). The FDR-corrected p-value was considered significant at p-value < 0.05.
We performed the same analysis for GM cortical thickness. The cortical thickness of each of the 68 Desikan-Killiany ROI was evaluated for its association with cognitive scores and disease progression.
We used MATLAB (MathWorks R2020a, Natick, MA, USA) and BrainNet viewer (http://www.nitrc.org.projects.bnv) for the statistical analysis and visualization of the results.
Results
Demographics and T1w/T2w ratio map
Table 1 shows the demographic characteristics of the study population. The mean WMH volume was 8.61 cm3 (± 5.05), which was comparable to that found in patients with AD in a previous study30. The average anatomical distribution of the T1w/T2w ratio values across the WM and GM in CU participants is shown in Fig. 1. We observed higher T1w/T2w ratios in the WM than in the GM. Furthermore, across the GM, high T1w/T2w ratios were found in the sensory-motor and visual cortices, whereas low T1w/T2w ratios were found in the temporal (pole), anterior cingulate cortex, and frontal areas (Fig. 1).
Association with cognitive state
We observed a significant decrease in the global WM T1w/T2w ratio between CU and ADD groups (P-value = 0.023) (Fig. 2A).
None of the WM track showed significant changes in T1w/T2w ratio between the diagnostic groups but seven WM tracts showed marginal (uncorrected P-value < 0.05) decreases in T1w/T2w ratio between CU and ADD groups (Fig. 2B, Supplementary Table 2).
Association with cognitive score
Among the various cognitive scores, the executive function score showed significant positive associations with the T1w/T2w ratio in the bilateral cruses of the fornix, left anterior internal capsule, left sagittal stratum, and body of the corpus callosum (Fig. 3, Table 2). The results showed that a higher T1w/T2w ratio in WM tracts was associated with higher executive function.
Of the various cognitive scores, MMSE and memory function scores showed significant positive associations with cortical thickness in the bilateral entorhinal cortices (Fig. 3, Table 3).
Association with disease progression
There was a marginal interaction between the T1w/T2w ratio of the left anterior internal capsule and time of longitudinal change in CDR-SB (T-value − 3.31, FDR corrected P-value 0.05, P-value 0.001). Including the time × WM T1w/T2w ratio as an interaction term improved the model fit (model with interaction term, Akaike’s information criterion (AIC) = 527.08, Bayesian information criterion (BIC) = 556.14; model without interaction term, AIC = 535.25, BIC = 561.40). The results showed that a higher T1w/T2w ratio in the left anterior internal capsule attenuated the increase in the CDR-SB over time (Fig. 4, Table 4).
None of the cortical regions showed a significant interaction between cortical thickness and time on longitudinal changes in CDR-SB.
Discussion
This study aimed to (1) measure the T1w/T2w ratio in WM and (2) examine its association with cognitive function and disease progression. Our main findings are as follows. Firstly, global WM T1w/T2w ratio was decreased in patients with ADD. Secondly the WM T1w/T2w ratio showed a significant association with executive function. Lastly, the WM T1w/T2w ratio showed a marginal association with disease progression.
We demonstrated that global WM T1w/T2 ratio was decreased in patients with ADD. This may reflect the widespread demyelination, seen in the WM of AD brain in previous studies31,3,32.
We demonstrated that the WM T1w/T2w ratio is significantly and positively associated with executive function. Notably, this association was independent of the level of WMH and was not observed in the GM cortical thickness. This finding suggests that the WM T1w/T2w ratio image may provide additional information for AD to conventional T1w (measuring cortical thickness) and T2w (measuring WMH) MRI.
Significant associations between the WM T1w/T2w ratio and executive function were found within the fornix, sagittal stratum, anterior internal capsule, and body of the corpus callosum. These WM tracts have frequently been reported in previous AD studies. The fornix connects the hippocampus to the septal nuclei and mammillary bodies in the hypothalamus, an essential component of memory formation and consolidation33. Previous studies have demonstrated that fornix integrity is impaired in early AD and may predict AD development33,34,35. The sagittal stratum contains the inferior fronto-occipital fasciculus, which connects the frontal and occipital cortices. Previous studies demonstrated that functional and structural connectivity in sagittal stratum are impaired in AD36,37. The anterior internal capsule connects the thalamus and the prefrontal cortex, which are crucial components of higher-order cognition38. Previous studies have shown that structural connectivity in the anterior internal capsule is impaired in AD39. The corpus callosum is a wide and thick WM track that includes several fibers connecting the two cortical hemispheres and providing interhemispheric transmission of information within the brain40. Many studies have reported callosal atrophy in patients with AD41,42.
Among the various cognitive domains, only executive function showed a significant association with WM T1/T2 ratio. Although memory impairment is an important symptom of early AD, executive dysfunction is also frequently observed43. Our results correspond with those of previous studies, demonstrating an association between WM integrity with executive function44,45. Notably, among other cognitive functions, executive function showed the greatest association with WM integrities46,47. Considering that the neural substrates of executive function are long-distance projections from the prefrontal to posterior brain regions, deterioration of fiber tracts is expected to have a detrimental effect on executive function.
Interestingly, we observed a marginal interaction between the T1w/T2w ratio of the left anterior internal capsule and time on longitudinal changes in the CDR-SB. A higher T1w/T2w ratio in the left anterior internal capsule attenuated the increase in the CDR-SB over time. WM hyperintensities have been shown to predict AD progression48,49. Our findings are in line with previous findings, as the T1w/T2w ratio may help detect subtle WM integrity changes. However, the statistical significance was low. Therefore, this finding should be tested using a larger sample size and replicated using an independent dataset.
The anatomical distribution of the T1w/T2w ratios showed spatial similarity to a previously reported myelin map (Fig. 1)8. The T1w/T2w ratio was significantly higher in the WM than in the GM. Furthermore, across the cortices, the T1w/T2w ratio was highest in the primary sensory-motor and visual cortices, similar to previous myelin maps, where the primary sensory-motor and visual cortices were highly myelinated, whereas the neocortices were less myelinated.
This study had several limitations. First, the sample size was too small to detect WM regions with small effects and detect changes in WM T1w/T2w ratio between different diagnostic groups. Furthermore, none of the cortical regions were significantly associated with disease progression. Previous studies have shown that the degree of cortical atrophy is associated with the risk of progression from MCI to AD and with rapid progression in AD50,51,52,53. In the current study, there was a trend for some cortical regions (left pars triangularis, P-value = 0.05, T-value = − 1.941; right posterior cingulate, P-value = 0.05, T-value = − 1.931), but they were not statistically significant. Considering the sample size of previous studies53,54,55, we attributed our findings on cortical thickness to the small sample size. However, with this sample size and statistical power, we identified additional associations between the WM T1w/T2w ratio and cognition and disease progression, which were not identified using cortical thickness values. Nevertheless, future studies using larger sample sizes might identify additional associations between the T1w/T2w ratio and cognition.
Second, we performed regression analysis of the study population comprising of CU, MCI, and ADD. In the subgroup analysis of each diagnostic group, we observed significant associations between the WM T1w/T2w ratio and executive function in patients with ADD only, suggesting that the primary results of our study were mainly driven by the ADD group (Supplementary Table 3). Because the CU and MCI groups had smaller sample sizes than the ADD group, it was difficult to determine whether the lack of significance was due to differences in the sample size or disease status. Further studies with larger sample sizes are needed to investigate this issue.
Third, a recent study showed that WM T1w/T2w may not specifically reflect the myelin content. Rather, it may be a compound measure of other factors such as iron and fiber density, other glial cells, elements of the extracellular space, and vasculature20. Similar to a previous study20, we observed a high T1w/T2w ratio in the red nucleus, substantia nigra, and globus pallidus (Supplementary Fig. 2), where myelin content is known to be low. Previous studies on AD have consistently demonstrated an increase in iron content in both the cerebral cortex and white matter56. The presence of iron in free radical reactions may contribute to oxidative damage in AD brains and cause white matter changes57. Based on findings from the previous studies, if the T1w/T2w ratio in the corpus callosum reflects the level of iron content, T1w/T2w ratio in the corpus callosum should show a negative association with executive function. However, in our study, the T1w/T2w ratio in the corpus callosum was positively associated with executive function. A plausible alternative explanation for these findings is that the T1w/T2w signal in the corpus callosum reflects varying axonal diameters of the fibers, and changes in the fiber integrity of the corpus callosum might be associated with executive function. Nevertheless, our findings should be interpreted with caution, and additional studies using pathological data are needed for a better understanding of this.
In conclusion, we created a T1w/T2w ratio map that corresponds to a known myelin distribution in the brain. We demonstrated that the WM T1w/T2w ratio was associated with executive function and disease progression, suggesting that it is a novel neuroimaging marker of AD.
Data availability
The datasets used during the current study are available from the corresponding author on reasonable request.
References
Braak, H. & Braak, E. Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol. 1(3), 213–216 (1991).
Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82(4), 239–259 (1991).
Nasrabady, S. E. et al. White matter changes in Alzheimer’s disease: A focus on myelin and oligodendrocytes. Acta Neuropathol. Commun. 6(1), 1–10 (2018).
Gulani, V. et al. Apparent diffusion tensor measurements in myelin-deficient rat spinal cords. Magn. Reson. Med. 45(2), 191–195 (2001).
Zhang, J. et al. Comparison of myelin water fraction from multiecho T2 decay curve and steady-state methods. Magn. Reson. Med. 73(1), 223–232 (2015).
Deoni, S. C. & Kolind, S. H. J. Investigating the stability of mcDESPOT myelin water fraction values derived using a stochastic region contraction approach. Magn. Reson. Med. 73(1), 161–169 (2015).
Hagiwara, A. et al. Myelin measurement: Comparison between simultaneous tissue relaxometry, magnetization transfer saturation index, and T1w/T2w ratio methods. Sci. Rep. 8(1), 10554 (2018).
Glasser, M. F. & Van Essen, D. C. J. Mapping human cortical areas in vivo based on myelin content as revealed by T1-and T2-weighted MRI. J. Neurosci. 31(32), 11597–11616 (2011).
Shams, Z., Norris, D. G. & Marques, J. P. J. A comparison of in vivo MRI based cortical myelin mapping using T1w/T2w and R1 mapping at 3T. PLoS ONE 14(7), e0218089 (2019).
Thompson, D. K. et al. Brain white matter development over the first 13 years in very preterm and typically developing children based on the T1-w/T2-w ratio. Neurology 98(9), e924–e937 (2022).
Lee, K., et al. Early postnatal myelin content estimate of white matter via T1w/T2w ratio. Proc. SPIE 9417, Medical Imaging 2015: Biomedical applications in molecular, structural, and functional imaging, 94171R. (2015).
Dipnall, L. M. et al. Childhood development of brain white matter myelin: A longitudinal T1w/T2w-ratio study. Brain Struct. Funct. https://doi.org/10.1007/s00429-023-02718-8 (2023).
Colmenares, A. M. et al. White matter plasticity in healthy older adults: The effects of aerobic exercise. Neuroimage 239, 118305 (2021).
Beer, A. et al. Tissue damage within normal appearing white matter in early multiple sclerosis: Assessment by the ratio of T1-and T2-weighted MR image intensity. J. Neurol. 263, 1495–1502 (2016).
Van Es, A. et al. Magnetization transfer imaging of gray and white matter in mild cognitive impairment and Alzheimer’s disease. Neurol. Aging 27(12), 1757–1762 (2006).
Stricker, N. H. et al. Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer’s disease supports retrogenesis. Neuroimage 45(1), 10–16 (2009).
Fornari, E. et al. Demyelination of superficial white matter in early Alzheimer’s disease: A magnetization transfer imaging study. Neurobiol. Aging 33(2), 428.e7-428.e19 (2012).
Luo, X. et al. Application of T1-/T2-weighted ratio mapping to elucidate intracortical demyelination process in the Alzheimer’s disease continuum. Front. Neurosci. 13, 904 (2019).
Pelkmans, W. et al. Gray matter T1-w/T2-w ratios are higher in Alzheimer’s disease. Human Brain Mapp. 40(13), 3900–3909 (2019).
Sandrone, S. et al. Mapping myelin in white matter with T1-weighted/T2-weighted maps: Discrepancy with histology and other myelin MRI measures. Brain Struct. Funct. 228, 525–535 (2023).
Petersen, R. C. Mild cognitive impairment. N. Engl. J. Med. 364(23), 2227–2234 (2011).
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement. 7(3), 263–269 (2011).
Ahn, H.-J. et al. Seoul Neuropsychological Screening Battery-dementia version (SNSB-D): A useful tool for assessing and monitoring cognitive impairments in dementia patients. J. Korean Med. Sci. 25(7), 1071–1076 (2011).
Schmidt, P. et al. An automated tool for detection of FLAIR-hyperintense white-matter lesions in multiple sclerosis. NeuroImage 59(4), 3774–3783 (2012).
Olsson, E. et al. White matter lesion assessment in patients with cognitive impairment and healthy controls: Reliability comparisons between visual rating, a manual, and an automatic volumetrical MRI method—The Gothenburg MCI study. J. Aging Res. 2013, 10 (2013).
Valdés Hernández, M. C. et al. Close correlation between quantitative and qualitative assessments of white matter lesions. Neuroepidemiology 40(1), 13–22 (2012).
Ganzetti, M., Wenderoth, N. & Mantini, D. J. Whole brain myelin mapping using T1-and T2-weighted MR imaging data. Front. Hum. Neurosci. 8, 671 (2014).
Delor, I. et al. Modeling Alzheimer’s disease progression using disease onset time and disease trajectory concepts applied to CDR-SOB scores from ADNI. CPT Pharmacomet. Syst. Pharmacol. 2(10), 1–10 (2013).
Cedarbaum, J. M. et al. Rationale for use of the Clinical Dementia Rating Sum of Boxes as a primary outcome measure for Alzheimer’s disease clinical trials. Alzheimer’s Dement. 9(1), S45–S55 (2013).
Garnier-Crussard, A. et al. White matter hyperintensity topography in Alzheimer’s disease and links to cognition. Alzheimer’s Dement. 18(3), 422–433 (2022).
Caso, F., Agosta, F. & Filippi, M. J. Insights into white matter damage in Alzheimer’s disease: From postmortem to in vivo diffusion tensor MRI studies. Neurodegener. Dis. 16(1–2), 26–33 (2016).
Sachdev, P. S. et al. Is Alzheimer’s a disease of the white matter?. Curr. Opin. Psychiatry 26(3), 244–251 (2013).
Oishi, K. & Lyketsos, C. G. Alzheimer’s disease and the fornix. Front. Aging Neurosci. 6, 241 (2014).
Mielke, M. M. et al. Fornix integrity and hippocampal volume predict memory decline and progression to Alzheimer’s disease. Alzheimer’s Dement. 8(2), 105–113 (2012).
Nowrangi, M. A. & Rosenberg, P. B. The fornix in mild cognitive impairment and Alzheimer’s disease. Front. Aging Neurosci. 7, 1 (2015).
Qiu, A. et al. Surface-based analysis on shape and fractional anisotropy of white matter tracts in Alzheimer’s disease. PLoS ONE 5(3), e9811 (2010).
Gao, Y. et al. Functional connectivity of white matter as a biomarker of cognitive decline in Alzheimer’s disease. PLoS ONE 15(10), e0240513 (2020).
Vanderah, T. W. & Gould, D. J. Nolte’s The Human Brain: An Introduction to its Functional Anatomy (Elsevier Health Sciences, 2020).
Mayo, C. D. et al. Relationship between DTI metrics and cognitive function in Alzheimer’s disease. Front. Aging Neurosci. 10, 436 (2019).
Aboitiz, F. et al. Fiber composition of the human corpus callosum. Brain Res. 598(1–2), 143–153 (1992).
Fellgiebel, A. et al. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol. Aging 26(8), 1193–1198 (2005).
Yamauchi, H. et al. Comparison of the pattern of atrophy of the corpus callosum in frontotemporal dementia, progressive supranuclear palsy, and Alzheimer’s disease. J. Neurol. Neurosurg. Psychiatry 69(5), 623–629 (2000).
Kirova, A. M., Bays, R. B. & Lagalwar, S. J. Working memory and executive function decline across normal aging, mild cognitive impairment, and Alzheimer’s disease. BioMed Res. Int. 2015, 1–9 (2015).
Gunning-Dixon, F. M. & Raz, N. J. N. The cognitive correlates of white matter abnormalities in normal aging: A quantitative review. Neuropsychology 14(2), 224 (2000).
Yuan, P., Raz, N. J. N. & Reviews, B. Prefrontal cortex and executive functions in healthy adults: A meta-analysis of structural neuroimaging studies. Neurosci. Biobehav. Rev. 42, 180–192 (2014).
Bennett, I. J. & Madden, D. J. J. N. Disconnected aging: Cerebral white matter integrity and age-related differences in cognition. Neuroscience 276, 187–205 (2014).
Van Den Berg, E. et al. White matter hyperintensities and cognition in mild cognitive impairment and Alzheimer’s disease: A domain-specific meta-analysis. J. Alzheimer’s Dis. 63(2), 515–527 (2018).
Prasad, K. et al. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer’s disease in a clinic cohort. Dement. Geriatr. Cogn. Disord. 31(6), 431–434 (2011).
Mortamais, M., Artero, S. & Ritchie, K. J. White matter hyperintensities as early and independent predictors of Alzheimer’s disease risk. J. Alzheimer’s Dis. 42(s4), S393–S400 (2014).
Kim, H.-R. et al. Visual rating of posterior atrophy as a marker of progression to dementia in mild cognitive impairment patients. J. Alzheimer’s Dis. 55(1), 137–146 (2017).
Eskildsen, S. F. et al. Structural imaging biomarkers of Alzheimer’s disease: Predicting disease progression. Neurobiol. Aging 36, S23–S31 (2015).
Cardenas, V. et al. Brain atrophy associated with baseline and longitudinal measures of cognition. Neurobiol. Aging 32(4), 572–580 (2011).
Velayudhan, L. et al. Entorhinal cortex thickness predicts cognitive decline in Alzheimer’s disease. J. Alzheimer’s Dis. 33(3), 755–766 (2013).
Cheng, Y.-W. et al. Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease. Alzheimer Res. Ther. 7(1), 1–8 (2015).
Suh, J. et al. The usefulness of visual rating of posterior atrophy in predicting rapid cognitive decline in Alzheimer disease: A preliminary study. Int. J. Geriatr. Psychiatry 34(4), 625–632 (2019).
Lane, D. J., Ayton, S. & Bush, A. I. Iron and Alzheimer’s disease: An update on emerging mechanisms. J. Alzheimer’s Dis. 64(s1), S379–S395 (2018).
Ling, H.-W. et al. Could iron accumulation be an etiology of the white matter change in Alzheimer’s disease: Using phase imaging to detect white matter iron deposition based on diffusion tensor imaging. Dement. Geriatr. Cogn. Disord. 31(4), 300–308 (2011).
Funding
This study was supported by the National Priority Research Center Program Grant (NRF- 2021R1A6A1A03038865), the Basic Science Research Program Grant (NRF- 2020R1A2C3008295), and Institute of Information & communications Technology Planning & Evaluation Grant (No.1711195685) funded by the Korean government.
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Lee, SN., Woo, SH., Lee, E.J. et al. Association between T1w/T2w ratio in white matter and cognitive function in Alzheimer’s disease. Sci Rep 14, 7228 (2024). https://doi.org/10.1038/s41598-024-57287-5
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-57287-5
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.